Yamazaki K - Search Results

1

A randomized phase II study of combination therapy with S-1, oral leucovorin, and oxaliplatin (SOL) and mFOLFOX6 in patients with previously untreated metastatic colorectal cancer.

Yamazaki K, Kuwano H, Ojima H, Otsuji T, Kato T, Shimada K, Hyodo I, Nishina T, Shirao K, Esaki T, Ohishi T, Denda T, Takeuchi M, Boku N. Yamazaki K, et al. Cancer Chemother Pharmacol. 2015 Mar;75(3):569-77. doi: 10.1007/s00280-015-2676-0. Epub 2015 Jan 10. Cancer Chemother Pharmacol. 2015. PMID: 25575764 Clinical Trial.

2

Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel.

Matsuoka M, Boku N, Yoshino T, Hironaka S, Onozawa Y, Fukutomi A, Zenda S, Yamazaki K, Yasui H, Hasuike N, Inui T, Yamaguchi Y, Ono H, Kamata M. Matsuoka M, et al. Among authors: yamazaki k. Int J Clin Oncol. 2005 Dec;10(6):429-32. doi: 10.1007/s10147-005-0502-0. Int J Clin Oncol. 2005. PMID: 16369748

3

[IFL].

Yamazaki K, Yoshino T, Boku N. Yamazaki K, et al. Gan To Kagaku Ryoho. 2006 Jul;33(7):907-10. Gan To Kagaku Ryoho. 2006. PMID: 16835478 Review. Japanese.

4

The role of the outpatient clinic in chemotherapy for patients with unresectable or recurrent gastric cancer.

Yamazaki K, Boku N, Shibamoto K, Yasui H, Fukutomi A, Yoshino T, Hironaka S, Onozawa Y, Otake Y, Hasuike N, Matsubayashi H, Inui T, Yamaguchi Y, Ono H. Yamazaki K, et al. Jpn J Clin Oncol. 2007 Feb;37(2):96-101. doi: 10.1093/jjco/hyl145. Epub 2007 Feb 1. Jpn J Clin Oncol. 2007. PMID: 17272316

5

[Bevacizumab (Avastin)].

Yamazaki K, Yoshino T, Boku N. Yamazaki K, et al. Gan To Kagaku Ryoho. 2007 Aug;34(8):1183-91. Gan To Kagaku Ryoho. 2007. PMID: 17687199 Review. Japanese.

6

Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.

Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamaguchi Y, Hasuike N, Yamazaki K, Machida N, Ono H. Yoshino T, et al. Among authors: yamazaki k. Jpn J Clin Oncol. 2007 Sep;37(9):686-91. doi: 10.1093/jjco/hym091. Epub 2007 Aug 24. Jpn J Clin Oncol. 2007. PMID: 17720736

7

A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.

Yamazaki K, Hironaka S, Boku N, Yasui H, Fukutomi A, Yoshino T, Onozawa Y, Hasuike N, Inui T, Yamaguchi Y, Ono H. Yamazaki K, et al. Int J Clin Oncol. 2008 Apr;13(2):150-5. doi: 10.1007/s10147-007-0738-y. Epub 2008 May 8. Int J Clin Oncol. 2008. PMID: 18463960

8

[Molecular target therapy and chemotherapy for advanced colorectal cancer].

Nakashima K, Yamazaki K, Boku N. Nakashima K, et al. Among authors: yamazaki k. Gan To Kagaku Ryoho. 2008 May;35(5):725-30. Gan To Kagaku Ryoho. 2008. PMID: 18487907 Review. Japanese.

9

Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancer.

Machida N, Yoshino T, Boku N, Hironaka S, Onozawa Y, Fukutomi A, Yamazaki K, Yasui H, Taku K, Asaka M. Machida N, et al. Among authors: yamazaki k. Jpn J Clin Oncol. 2008 Oct;38(10):689-94. doi: 10.1093/jjco/hyn086. Jpn J Clin Oncol. 2008. PMID: 18845522

10

Irinotecan plus cisplatin therapy and S-1 plus cisplatin therapy for advanced or recurrent gastric cancer in a single institution.

Nakashima K, Hironaka S, Boku N, Onozawa Y, Fukutomi A, Yamazaki K, Yasui H, Taku K, Kojima T, Machida N. Nakashima K, et al. Among authors: yamazaki k. Jpn J Clin Oncol. 2008 Dec;38(12):810-5. doi: 10.1093/jjco/hyn109. Epub 2008 Nov 6. Jpn J Clin Oncol. 2008. PMID: 18988666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,331 results

Search Page

Filters